SARS-CoV-2 Seroprevalence Across a Diverse Cohort of Healthcare Workers

Author:

Ebinger Joseph E.,Botwin Gregory J.,Albert Christine M.,Alotaibi Mona,Arditi Moshe,Berg Anders H.,Binek Aleksandra,Botting Patrick,Fert-Bober Justyna,Figueiredo Jane C.,Grein Jonathan D.,Hasan Wohaib,Henglin Mir,Hussain Shehnaz K.,Jain Mohit,Joung Sandy,Karin Michael,Kim Elizabeth H.,Li Dalin,Liu Yunxian,Luong Eric,McGovern Dermot P.B.,Merchant Akil,Merin Noah,Miles Peggy B.,Minissian Margo,Nguyen Trevor-Trung,Raedschelders Koen,Rashid Mohamad A.,Riera Celine E.,Riggs Richard V.,Sharma Sonia,Sternbach Sarah,Sun Nancy,Tourtellotte Warren G.,Van Eyk Jennifer E.,Sobhani Kimia,Braun Jonathan G.,Cheng Susan

Abstract

ABSTRACTImportanceAntibody testing is important for understanding patterns of exposure and potential immunity to SARS-CoV-2. Prior data on seroprevalence have been subject to variations in selection of individuals and nature as well as timing of testing in relation to exposures.ObjectiveWe sought to determine the extent of SARS-CoV-2 seroprevalance and the factors associated with seroprevelance across a diverse cohort of healthcare workers.DesignObservational cohort study of healthcare workers, including SARS-CoV-2 serology testing and participant questionaires.ParticipantsA diverse and unselected population of adults (n=6,062) employed in a multi-site healthcare delivery system located in Los Angeles County, including individuals with direct patient contact and others with non-patient-oriented work functions.ExposureExposure and infection with the SARS-CoV-2 virus, as determined by seropositivity.Main OutcomesUsing Bayesian and multi-variate analyses, we estimated seroprevalence and factors associated with seropositivity and antibody titers, including pre-existing demographic and clinical characteristics; potential Covid-19 illness related exposures; and, symptoms consistent with Covid-19 infection.ResultsWe observed a seroprevalence rate of 4.1%, with anosmia as the most prominently associated self-reported symptom in addition to fever, dry cough, anorexia, and myalgias. After adjusting for potential confounders, pre-existing medical conditions were not associated with antibody positivity. However, seroprevalence was associated with younger age, Hispanic ethnicity, and African-American race, as well as presence of either a personal or household member having a prior diagnosis of Covid-19. Importantly, African American race and Hispanic ethnicity were associated with antibody positivity even after adjusting for personal Covid-19 diagnosis status, suggesting the contribution of unmeasured structural or societally factors. Notably, number of people, or children, in the home was not associated with antibody positivity.Conclusion and RelevanceThe demographic factors associated with SARS-CoV-2 seroprevalence among our healthcare workers underscore the importance of exposure sources beyond the workplace. The size and diversity of our study population, combined with robust survey and modeling techniques, provide a vibrant picture of the demographic factors, exposures, and symptoms that can identify individuals with susceptibility as well as potential to mount an immune response to Covid-19.Key PointsQuestionWhat is the SARS-CoV-2 IgG seroprevalence rate across a large and diverse healthcare worker population, and which clinical, envionrmental, and symptom-based measures are associated with seropositivity?FindingsWe observed a seroprevalence rate of 4.1%. Adjusting for potential confounders, seropositivity was associated with younger age, Hispanic ethnicity, African-American race, and the symptom of anosmia, while not significantly associated with any pre-existing medical conditions.MeaningFactors associated with SARS-CoV-2 seroprevalence among our healthcare workers underscore the importance of exposure sources beyond the workplace.

Publisher

Cold Spring Harbor Laboratory

Reference48 articles.

1. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward;Science Immunology,2020

2. Health CfDaR. Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency. In: Administraction FaD, ed: Dockets Management; 2020.

3. SARS-CoV-2 infection serology: a useful tool to overcome lockdown?;Cell Death Discov,2020

4. Developing antibody tests for SARS-CoV-2;Lancet (London, England),2020

5. Will antibody tests for the coronavirus really change everything?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3